VBIO
Valion Bio IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$1.72M
P/E Ratio
—
EPS
$-6.66
Beta
1.87
52W High
$5.60
52W Low
$0.52
50-Day MA
$0.95
200-Day MA
$1.66
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Valion Bio Inc
Vitality Biopharma, Inc. focuses on developing cannabinoid pharmaceutical prodrugs in the United States. The company is headquartered in Los Angeles, California.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-12.15M |
| Operating Margin | 0.00% |
| Return on Equity | -182.20% |
| Return on Assets | -36.20% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $6.65 |
| Price-to-Book | 0.23 |
| Price-to-Sales (TTM) | 1.52 |
| EV/Revenue | 0.563 |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $3.20M |
| Float | $3.07M |
| % Insiders | 1.98% |
| % Institutions | 14.78% |
Historical Volatility
HV 10-Day
181.67%
HV 20-Day
137.50%
HV 30-Day
135.78%
HV 60-Day
143.86%
HV Rank
82.9%
Volatility is currently expanding
More HEALTHCARE Stocks
Data last updated: 6/13/2026